Issue

  • Issue: 
    12

    WOUNDS 2005 YEAR IN REVIEW

    December, 2005

    Dear Readers,

    The December issue of WOUNDS marks the third full year for monthly issuance of the journal. This publication frequency allows us to minimize the period of time between manuscript acceptance and publication. When we began this effort there was some concern that a growing number of journals in the wound-healing field might negatively impact the number of quality manuscripts submitted to WOUNDS. Thankfully, this has not been the case, as submission of good manuscripts has grown over the years. Of the 41 manuscripts accepted for pu

  • Issue: 
    12

    Prevalon™ Heel Protector Addresses Second Most Common Pressure Ulcer Site

    Sage Products (Cary, Ill) introduces a new device to protect patients’ feet, especially heels and ankles, from excessive pressure, friction, and shearing. Prevalon™ Pressure-Relieving Heel Protector provides effective pressure relief while helping prevent foot drop. The device elevates the foot and separates the heel from the mattress surface to float the heel. This provides total pressure relief for the heel while keeping it visible for easy monitoring between assessments. The device also has a foot-drop preve

  • Issue: 
    12

    INVANZ® Approved for Treatment of Moderate to Severe Foot Infection in Patients with Diabetes

    Merck & Co. Inc. (Whitehouse Station, NJ) announces approval from the US Food and Drug Administration (FDA) for INVANZ® (ertapenem), a once-daily injectable antibiotic treatment for moderate to severe complicated foot infection due to indicated pathogens in patients with diabetes without osteomyelitis. The approval was based on the results of the SIDESTEP study, the largest prospective, randomized, double-blind clinical trial ever conducted in patients with diabetes and moderate to se

  • Issue: 
    12

    Dear Readers: A multidisciplinary wound care team can serve as a focus for knowledge, understanding, and healing for all types of challenging wounds.1 Such a team approach can also improve wound-related patient outcomes other than healing, eg, reducing frequency and level of amputation in patients with diabetes,2,3 improving outcomes following hip fractures,4 or preventing pressure ulcers.5 Whether it is called “multidisciplinary” to emphasize the variety of disciplines on the wound care team or “interdisciplinary” to emphasize collabo

  • Issue: 
    12

    The Undersea and Hyperbaric Medical Society (UHMS) currently recognizes hyperbaric oxygen therapy (HBO) as an approved therapy for 13 pathologic entities.1 These are conditions for which HBO has substantial scientific support demonstrating therapeutic benefit. Hyperbaric oxygen is currently considered a primary treatment modality for carbon monoxide poisoning, cerebral arterial gas embolism, osteoradionecrosis, decompression sickness, and clostridial gas gangrene. It is also considered an adjunctive therapy for acute exceptional blood loss anemia, acute thermal burns, compromised s

  • Issue: 
    12

    Scar control is a major concern in burn wound management. When scarring occurs, the outcome may be associated with a loss of function or an undesirable cosmetic result. The functional problems may be severe enough to result in the inability to perform one’s usual work tasks. An unacceptable cosmetic result may lead to psychosocial concerns.
    Early wound closure results in less hypertrophic scarring. Early excision and grafting of deeper injuries expedites wound closure. A significant challenge remains in how to avoid hypertrophic scar formation in partial-thickness wounds that are allowed

  • Issue: 
    12

    The performance of dressings significantly affects wound healing and quality of life for patients.1 Despite extensive collective nursing care experience, uncertainty remains about the optimum choice of many parameters that affect dressing performance, such as the shape, extensibility, and fixing position of the dressings. The context of this study was an assessment of the potential for stereo-photogrammetry to provide quantitative information to support clinicians and dressing designers. Specifically, this was a pilot study to investigate the influence of skin deformation on the fi

Ostomy Wound Management

Press Release

ConvaTec and Boehringer Technologies Announce License Agreement


ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System

SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.


WOUNDS News Wire

CME Showcase

"Diabetic Peripheral Neuropathy"

Upcoming Accredited Webcast

Release Date: December 22, 2008

Expiration Date: December 22, 2009

This activity is supported by an educational grant from PamLabs.
This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).

To register for this Webcast, visit www.naccme.com/program/n-558/


"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"

Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009

Rebroadcasts

7:30-8:30 p.m. EDT
January 27, 2009

3-4 p.m. EDT
January 28, 2009

This activity is supported by an educational grant from Advanced Biohealing.
This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).

To register for this Webcast, visit www.naccme.com/program/n-550/


MRSA And Diabetic Foot Wounds: Where Do We Go From Here?
Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).

 

PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies
Archived Accredited Webcast with Q&A:
This activity is supported by an educational grant from Baxter Healthcare Corporation.


Maintenance Debridement: A New Look at Science and Art
Accredited Webcast with Q&A:
November 17, 2008 at 3:00pm EST
This activity is supported by an educational grant from HealthPoint Ltd.
 

REVIEW OUR OTHER
WOUND CARE BRANDS

Check out our other resources for healthcare professionals of all specialties.

  • Ostomy Wound Management
  • Todays Wound Clinic
  • Podiatry Today
  • Skin and Aging